Effects of carnitine and its derivatives on gastric acid secretion in rats

Pharmacological Research

Volumn 34, Issue 5-6, 1996, Pages 219-224

  Valoti, Massimo ^a   Benocci, Alberto ^a   Marazova, Katia ^b   Mantovani, Piero ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Adrenergic mechanism; Carnitine; Carnitine derivatives; Gastric secretion

Indexed keywords

ACETYLCARNITINE; ACETYLCHOLINESTERASE; ACETYLTHIOCHOLINE; ATROPINE; CARNITINE; CARNITINE DERIVATIVE; PHYSOSTIGMINE; POSTSYNAPTIC RECEPTOR; PROPIONYLCARNITINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT; SPORTS MEDICINE; STOMACH ACID; STOMACH ACID SECRETION; SYMPATHETIC NERVE CELL;

EID: 0030295167     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0091     Document Type: Article

References (25)

1. 1. Fritz IB. Factor influencing the rate of long chain fatty acid oxidation and synthesis in mammalian system. Physiol Rev 1961; 41: 52-129.
2. 2. Blum K, Seifter E, Seifter J. The pharmacology of D-and L-carnitine and D-and L-acetylcarnitine in comparison with choline and acetylcholine. J Pharmacol Expt Ther 1971; 178: 331-8.
3. 3. Martignoni E, Facchinetti F, Sances G, Petragli F, Nappi G, Gennazzani AR. Acetyl-L-carnitine acutely administered raises-β-endorphin and cortisol plasma levels in humans. Clin Pharmacol Sci 1988; 11: 472-7.
4. 4. Ghilardi O, Milano S, Ramacci MT, Angelucci L. Effect of Acetyl-L-Carnitine chronic treatment on discrimination models in aged rats. Physiol Behav 1988; 44: 769-73.
5. 5. Fritz IB, Arrigoni Martelli E. Sites of action of Carnitine and its derivatives on the cardiovascular system: interaction with membranes. Trend Pharmacol Sci 1993; 14: 355-60.
6. 6. Ferraru R et al. Effect on myocardial metabolism in coronary artery disease. Clin Trials J 1984; 21: 40.
7. 7. Martindale Reynolds JEF (ed) In: The extra pharmacopoeia. 13th ed, London: The Pharmaceutical Press, 1993, p. 1037.
8. 8. Mantovani P. Acetyl-L-carnitine stimulates acid gastric secretion in rats through a peripheral cholinergic mechanism. Med Sci Res 1991; 19: 209-10.
9. 9. Pagani F, Brambilla A, Schiavone A, Giachetti A. Cholinergic control of gastric acid secretion. Arch Pharmacol 1985; 329: 45-9.
10. 10. Elmann GL, Courteny KD, Andres V, Featherstone RM. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 788-95.
11. 11. Revel L, Ferrari F, Makovec F, Rovati LC, Impicciatore M. Characterization of antigastrin activity in vivo of CR 2194, a new R-4-benzamido-5-oxo-pentanoic acid derivate. Eur J Pharmacol 1992; 216: 217-41.
12. 12. Salim AS. Inhibition of basal and insulin-stimulated gastric acid secretion. J Pharm Pharmacol 1987; 39: 562-64.
13. 13. Salin AS. The role of adrenoceptors in the mechanism of reserpine induced stimulation of gastric acid secretion in the rat. J Pharm Pharmacol 1988; 40: 448-50.
14. 14. Hodge AJ, Masarei JR, Catchpole BN. The role of sympathetic nervous system in hypoglycaemia-stimulated gastric secretion. Gut 1972; 13: 341-5.
15. 15. Hayes JR, Ardill J, Kennedy TL, Shanks RG, Buchanan KD. Stimulation of gastrin release by catecholamines. Lancet 1972; 1: 819-21.
16. 16. Yokotani K, Muramatsu I, Fujjawara M. Alpha-1 and Alpha-2 type adrenoceptors involved in the inhibitory effect of aplanchic nerves on parasympathetically stimulated gastric acid secretion in rats. Exp Pharmacol 1984; 229: 305-10.
17. 17. Del Tacca M, Soldani G, Bernardini C, Martinotti E, Impicciatore M. Pharmacological studies on the mechanism underlying and excitatory effects of clonidine on gastric acid secretion. Eur J Pharmacol 1982; 81: 255-61.
18. 18. Gidener S, LePard KJ, Stephens RL Jr. 8 OH-DPAT stimulates gastric acid secretion through a vagal-independent, adrenal-mediated mechanism. Eur J Pharmacol 1995; 284: 19-24.
19. 2A-receptor subtypes modulate gastric acid secretion. Abstract XXVII Congress of the Italian Society of Pharmacology Torino. 25-29, IX, 1994, 664.
20. 20. Caruso A, Cutuli VMC, De Bernardis E, Leonardi G, Amico Roxas M. Protective effect of Propionil-L-Carnitine against PAF-induced rat paw aedema. Pharmacol Res 1995; 31: 67-71.
21. 21. Hulsmann WC. Biochemical profile of Propionil-L-Carnitine. Cardiovasc Drugs Ther 1991; 5: 7-9.
22. 22. Bieber LL. Carnitine. Ann Rev Biochem 1988; 57: 261-83.
23. 23. Mancinelli A, Longo A, Shanahan K, Evans AM. Disposition of L-carnitine and Acetyl-L-Carnitine in the isolated perfused rat kidney. J Pharmacol Exp Ther 1995; 274/3: 1122-8.
24. 24. Visentini M, Bellasio R, Tacconi MT. Reye syndrome model in rats: protection against liver abnormalities by L-Carnitine and Acetyl-L-carnitine. J Pharmacol Exp Ther 1995; 275/2: 1069-75.
25. 25. Ratnakumari L, Qureshi IA, Maysinger D, Butterworth RF. Developmental deficiency of the cholinergic system in congenitally hyperammonemic SPF mice: effect of Acetyl-L-Carnitine. J Pharmacol Exp Ther 1995; 274/1: 437-43.